Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PSA/IL-2/GM-CSF vaccine - Oncbiomune Pharmaceuticals

Next Previous
X
Search
Drug Profile

PSA/IL-2/GM-CSF vaccine - Oncbiomune Pharmaceuticals

Alternative Names: ProscaVax; Prostatac; Prostate cancer vaccine - Oncbiomune; PSA-IL-2-GM-CSF-vaccine

Latest Information Update: 28 Nov 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Oncbiomune; United States Army
  • Developer OncBioMune
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Prostate cancer

Most Recent Events

  • 28 Nov 2024 No recent reports of development identified for phase-I development in Prostate-cancer(Second-line therapy or greater) in USA (Intradermal, Injection)
  • 30 Nov 2022 PSA/IL-2/GM-CSF vaccine is still in phase-I trials for Prostate-cancer (Second-line therapy or greater) in USA (Intradermal, Injection) (Oncbiomune Pharmaceuticals pipeline, November 2022)
  • 30 Nov 2022 PSA/IL-2/GM-CSF vaccine is still in phase-II clinical trials for Prostate cancer (First-line therapy, Early-stage disease) in USA (Intradermal) (Oncbiomune Pharmaceuticals pipeline, November 2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top